Lanean...
Fibroblast growth factor family as a potential target in the treatment of hepatocellular carcinoma
Hepatocellular cancer (HCC) is currently the third leading cause of cancer death worldwide. The prognosis of patients diagnosed with late-stage disease is dismal due to high resistance to conventional systemic therapies. The introduction of sorafenib, despite its limited efficacy, as the standard sy...
Gorde:
| Argitaratua izan da: | J Hepatocell Carcinoma |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Dove Medical Press
2014
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4918266/ https://ncbi.nlm.nih.gov/pubmed/27508175 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JHC.S48958 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|